CKD-215

· Chong Kun Dang Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-215, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]

See pricing